½ÃÀ庸°í¼­
»óǰÄÚµå
1594444

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Nephrology & Urology Devices Market by Product (PCN Catheters, Renal Dilators, Stone Basket), Application (Bladder Disorders, Kidney Diseases, Urolithiasis), End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº 2023³â 157¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 173¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 10.74% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 322¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå¿¡´Â ½ÅÀå ¹× ¿ä·Î Áúȯ°ú »óŸ¦ Ä¡·áÇÏ°í °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±â°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â Åõ¼® Àåºñ, ¿ä°ü ½ºÅÙÆ®, ½ÅÀå·ç ŰƮ, ¼â¼®±â, ³»½Ã°æ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀåºñÀÇ Çʿ伺Àº Àα¸ÀÇ °í·ÉÈ­¿Í ºñ¸¸ ¹× ´ç´¢º´ÀÇ Áõ°¡·Î ÀÎÇØ ¸¸¼º ½ÅÀå Áúȯ, ¿ä·Î °¨¿° ¹× Àü¸³¼± ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ÀçÅà ÀÇ·á ÇöÀå¿¡ Àû¿ëµÇ¾î ÀÌ·¯ÇÑ ÃÖÁ¾ »ç¿ë ȯ°æ¿¡¼­ ȯÀÚÀÇ Áø´Ü, Ä¡·á ¹× °ü¸®¿¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ȯÀÚÀÇ ¿¹ÈÄ¿Í Æí¾ÈÇÔÀ» °³¼±Çϱâ À§ÇÑ ÃÖ¼Òħ½À ¼ö¼ú ¹× Çõ½ÅÀûÀÎ Á¦Ç° ¼³°è¿Í °°Àº ±â¼úÀû Áøº¸¿¡ Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¹Î°£ ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ º¸±Þ Áõ°¡·Î ÀÎÇØ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ´Â ½ÅÈï ½ÃÀå¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ±î´Ù·Î¿î ±ÔÁ¦ ȯ°æ, ³ôÀº Ä¡·áºñ, Àú°³¹ß Áö¿ªÀÇ ÀÇ·á ½Ã¼³ Á¢±Ù¼º Á¦ÇÑ µîÀÇ ¹®Á¦°¡ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀº ÈÞ´ë¿ë ¹× °¡Á¤¿ë ±â±â °³¹ß, ¿¹Ãø Áø´ÜÀ» À§ÇÑ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ±â±âÀÇ »ýüÀûÇÕ¼º ¹× È¿À²¼º Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû ÀåÄ¡ ÇÏÀ̺긮µå ¹× Àç»ýÀÇ·á ±â¼ú¿¡ ´ëÇÑ Ã·´Ü ¿¬±¸µµ »õ·Î¿î ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϸç, ÁÖ¿ä ±â¾÷µéÀº R&D, Á¦ÈÞ ¹× ÇÕº´¿¡ ¸·´ëÇÑ ÅõÀÚ¸¦ ÅëÇØ Æ÷Æ®Æú¸®¿À¿Í ¼¼°è ÀÔÁö¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¼ºÀåÇϰíÀÚ ÇÏ´Â ±â¾÷µéÀº ÁøÈ­ÇÏ´Â °í°´ ´ÏÁ ÀÌÇØÇϰí, ¾ÖÇÁÅͼ­ºñ½º¿¡ ÁßÁ¡À» µÎ¾î Á¦Ç° Â÷º°È­¸¦ ²ÒÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¿ªµ¿¼ºÀ» ±Øº¹Çϱâ À§Çؼ­´Â ±â¼ú º¯È­¿¡ ´ëÇÑ ÀûÀÀ·Â°ú °­·ÂÇÑ ±ÔÁ¦ Áؼö ´É·ÂÀÌ ÇʼöÀûÀ̸ç, ÀÌ´Â Àü·«Àû °èȹ°ú Áö¼ÓÀûÀÎ Çõ½ÅÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 157¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 173¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 322¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 10.74%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ½ÅÀå ¹× ºñ´¢±â ÁúȯÀÇ ÀÌȯÀ² ¹× À¯º´·ü Áõ°¡
    • ÃÖ¼Òħ½ÀÀû, ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
    • ½ÅÀå-ºñ´¢±â ±â±â ±â´É Çâ»ó
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ½ÅÀå ¹× ºñ´¢±â ÀåÄ¡ÀÇ ³ôÀº ¼³Ä¡ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹°¡ÀÇ ÇコÄÉ¾î ¼­ºñ½º ÅõÀÚ Áõ°¡
    • ±â¼úÀûÀ¸·Î Áøº¸µÈ ÀåÄ¡¸¦ µµÀÔÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß Ȱµ¿
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ ºÎÁ·

Porter's Five Forces : ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ °æÀï »óȲ ÆÄ¾Ç

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû Æ÷Áö¼Å´×À» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ Á¦Ç° ¼Ò°³

½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå : Á¦Ç°º°

  • PCN Ä«Å×ÅÍ
  • ½ÅÀå È®Àå¾à
  • µ¹ ¹Ù½ºÄÏ
  • ¿ä°ü Ä«Å×ÅÍ
  • ¿ä°ü ½ºÅÙÆ®
  • ºñ´¢±â°ú °¡À̵å¿ÍÀ̾î

Á¦7Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå : ¿ëµµº°

  • ¹æ±¤Àå¾Ö
  • ½ÅÀåÁúȯ
  • ¿ä·Î°á¼®Áõ
  • ºñ´¢±â¾Ï°ú Àü¸³¼± ºñ´ëÁõ

Á¦8Àå ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard Inc.
  • Coloplast Ltd.
  • Convatec Inc.
  • Cook Group Incorporated
  • Dornier MedTech GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Medtronic plc
  • Nipro Corporation
  • Olympus Corporation
  • Teleflex Incorporated
  • Terumo Corporation
ksm 24.11.28

The Nephrology & Urology Devices Market was valued at USD 15.76 billion in 2023, expected to reach USD 17.38 billion in 2024, and is projected to grow at a CAGR of 10.74%, to USD 32.21 billion by 2030.

The nephrology and urology devices market encompasses medical devices used for treating and managing kidney and urinary tract diseases and conditions. The scope of this market includes dialysis equipment, ureteral stents, nephrostomy kits, lithotripters, and endoscopes, among others. The necessity of these devices arises from the increasing prevalence of chronic kidney diseases, urinary tract infections, and prostate disorders, driven by aging populations and rising obesity and diabetes rates. They are applied in hospitals, clinics, ambulatory surgical centers, and home care settings, serving patients for diagnosis, treatment, and management across these end-use scenarios. Market growth is significantly influenced by technological advancements, like minimally invasive procedures and innovative product designs aimed at improving patient outcomes and comfort. Potential opportunities lie in emerging markets due to the rising demand for healthcare infrastructure and the increasing penetration of private healthcare providers. However, challenges such as stringent regulatory environments, high treatment costs, and limited access to healthcare facilities in underdeveloped regions impede market expansion. Innovation in this field can focus on developing portable and home-use devices, integration of AI and machine learning for predictive diagnostics, and improving biocompatibility and efficiency of devices. Cutting-edge research on biologic-device hybrids and regenerative medicine techniques could also open new avenues. The market is highly competitive, with major players investing heavily in research and development, alliances, and mergers to enhance their portfolios and global presence. For businesses aiming for growth, understanding evolving customer needs and emphasizing robust after-sales services could differentiate offerings. The capability to adapt to technological changes and strong regulatory compliance will be crucial in navigating the future dynamics of the nephrology and urology devices market, highlighting the importance of strategic planning and continuous innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 15.76 billion
Estimated Year [2024] USD 17.38 billion
Forecast Year [2030] USD 32.21 billion
CAGR (%) 10.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nephrology & Urology Devices Market

The Nephrology & Urology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence and prevalence of nephrological & urological disorders
    • Increasing preference for minimally invasive and non-invasive treatment procedures
    • Improved functionality of nephrology & urology devices
  • Market Restraints
    • High installation cost of nephrology & urology devices
  • Market Opportunities
    • Increasing investment in healthcare services in developing economies
    • Ongoing research and development activities for introduction of technologically advanced devices
  • Market Challenges
    • Dearth of skilled medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Nephrology & Urology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nephrology & Urology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nephrology & Urology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nephrology & Urology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nephrology & Urology Devices Market

A detailed market share analysis in the Nephrology & Urology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nephrology & Urology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nephrology & Urology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nephrology & Urology Devices Market

A strategic analysis of the Nephrology & Urology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nephrology & Urology Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard Inc., Coloplast Ltd., Convatec Inc., Cook Group Incorporated, Dornier MedTech GmbH, Fresenius Medical Care AG & Co. KGaA, Hollister Incorporated, Medtronic plc, Nipro Corporation, Olympus Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Nephrology & Urology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across PCN Catheters, Renal Dilators, Stone Basket, Ureteral Catheters, Urinary Stents, and Urology Guidewires.
  • Based on Application, market is studied across Bladder Disorders, Kidney Diseases, Urolithiasis, and Urological Cancer & BPH.
  • Based on End-user, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of nephrological & urological disorders
      • 5.1.1.2. Increasing preference for minimally invasive and non-invasive treatment procedures
      • 5.1.1.3. Improved functionality of nephrology & urology devices
    • 5.1.2. Restraints
      • 5.1.2.1. High installation cost of nephrology & urology devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in healthcare services in developing economies
      • 5.1.3.2. Ongoing research and development activities for introduction of technologically advanced devices
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nephrology & Urology Devices Market, by Product

  • 6.1. Introduction
  • 6.2. PCN Catheters
  • 6.3. Renal Dilators
  • 6.4. Stone Basket
  • 6.5. Ureteral Catheters
  • 6.6. Urinary Stents
  • 6.7. Urology Guidewires

7. Nephrology & Urology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Bladder Disorders
  • 7.3. Kidney Diseases
  • 7.4. Urolithiasis
  • 7.5. Urological Cancer & BPH

8. Nephrology & Urology Devices Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Nephrology & Urology Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nephrology & Urology Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nephrology & Urology Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun SE
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. C. R. Bard Inc.
  • 5. Coloplast Ltd.
  • 6. Convatec Inc.
  • 7. Cook Group Incorporated
  • 8. Dornier MedTech GmbH
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. Hollister Incorporated
  • 11. Medtronic plc
  • 12. Nipro Corporation
  • 13. Olympus Corporation
  • 14. Teleflex Incorporated
  • 15. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦